Infectious Disease Litigation: Science, Law & Procedure
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing firstname.lastname@example.org; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
Modern technology offers new tools to better understand, track, and explain viral and bacterial spread in humans. In 2020, as COVID-19 overwhelmed governments and significant segments of the population and paralyzed many courts, we became painfully aware of the magnitude of risk carried around in tiny bacteria and viruses. COVID-19 has shown us that developing standards of care, treatments, and vaccines for emerging viruses and bacteria can take substantial time and resources. The rise in superbugs and drug-resistant bacteria, and the difficulty of treating these infections, have raised new questions about the balance between public health and global commerce. More than ever, practitioners need to think like scientists--following the facts and science to build a case. Like science, the law has not remained stagnant. Products, premises, and food outbreak liability law--all applicable to this type of litigation--have evolved through legislative acts, regulatory rulemaking, and the common law. This evolution has occurred parallel to the advances of science, purposeful or not.
While COVID-19 changed the original scope of this book by broadening the areas of inquiry, the basic idea remains the same: science and the law seldom remains static. The emergence of widespread contagion litigation has underscored key developments in both science and law. COVID-19 has highlighted that disputes over outbreaks are not limited to tort litigation. The pandemic has also seen a rise in insurance, contract, and employment cases related to COVID-19. All of these types of litigation now face epidemic- and pandemic-related questions. This book provides guidance for the practitioner who is handling any type of outbreak litigation, from complex disputes arising out of the COVID-19 pandemic to smaller localized outbreaks that require special expertise.
eBooks, CDs, downloadable content, and software purchases are non-cancellable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+™ for further legal research options. A valid subscription to Lexis+™ is required to access this content